Neuroscientists at the Massachusetts Institute of Technology have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light.
When targeted to specific neurons, they could potentially lead to new treatments for abnormal brain activity associated with disorders including chronic pain, epilepsy, brain injury and Parkinson's disease.
Such disorders could best be treated by silencing, rather than stimulating abnormal brain activity. These new tools, or 'super silencers,' exert exquisite control over the timing in which overactive neural circuits are shut down --an effect that is not possible with existing drugs or other conventional therapies.
The National Science Foundation's division of mathematical sciences supports the research through a grant to the Cognitive Rhythms Collaborative, which is comprised of four research groups in the Boston area focused on questions in neuroscience. The collaborative brings together researchers with expertise ranging from experimental design to mathematical modeling. The research paper, "High-Performance Genetically-Targetable Optical Neural Silencing by Light-Driven Proton Pumps," appears in the Jan. 7 issue of the journal Nature.
"Silencing different sets of neurons with different colors of light allows us to understand how they work together to implement brain functions," explains Ed Boyden, senior author of the study. "Using these new tools, we can look at two neural pathways and study how they compute together," he says.
The tools promise to help researchers understand how to control neural circuits, leading to new understandings and treatments for brain disorders. Boyden, the Benesse Career Development Professor in the MIT Media Lab and an associate member of the McGovern Institute for Brain Research at MIT, calls brain disorders "some of the biggest unmet medical needs in the world."
Boyden's 'super silencers' derive from two genes found in different natural organisms such as bacteria and fungi. These genes, referred to as Arch and Mac, are light-activated proteins that help the organisms make energy. When Arch and Mac are placed within neurons, researchers can inhibit their activity by shining light on them. Light activates the proteins, which lowers the voltage in the neurons and safely and effectively prevents them from firing. Arch is specifically sensitive to yellow light, while Mac is activated with blue light.
"In this way the brain can be programmed with different colors of light to study and possibly correct the corrupted neural computations that lead to disease," explains co-author Brian Chow, postdoctoral associate in Boyden's lab.
"Multicolor silencing dramatically increases the complexity with which you can study neural circuits," says co-author Xue Han, another postdoctoral researcher in Boyden's lab. "We will use these tools to parse out the neural mechanisms of cognition."
Determining whether Arch and Mac are safe and effective in monkeys will be a critical next step towards the potential use of these optical silencing tools in humans. Boyden plans to use these 'super silencers' to examine the neural circuits of cognition and emotion and to find targets in the brain that, when shut down, could relieve pain and treat epilepsy.
His group continues to mine the natural world for new and even more powerful tools to manipulate brain cell activity--tools that he hopes will empower scientists to explore neural circuits in ways never before possible.
Additional funding for this research was provided by the National Institutes of Health, the McGovern Institute Neurotechnology Program at MIT, the Department of Defense, the National Alliance for Research on Schizophrenia and Depression, the Alfred P. Sloan Foundation, Jerry and Marge Burnett, the Society for Neuroscience, the MIT Media Lab, the Benesse Foundation, the Wallace H. Coulter Foundation and the Helen Hay Whitney Foundation.
Bobbie Mixon | EurekAlert!
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.
But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...
Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.
The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...
Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters
Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
19.02.2018 | Materials Sciences
19.02.2018 | Materials Sciences
19.02.2018 | Life Sciences